Oragenics Inc (OGEN)

Apr 13, 2026

Earnings Recap: Is Oragenics Inc gaining market shareWeekly Stock Report & Weekly High Momentum Picks - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

Oragenics Doses First Patient in Phase IIa Trial for Potential Concussion Treatment - citybuzz -

Apr 13, 2026

Apr 13, 2026

Oragenics begins Phase IIa dosing of concussion drug ONP-002 in Australia - TipRanks

Apr 13, 2026

Apr 13, 2026

Oragenics Doses First Patient in Phase IIa Trial of ONP-002 for Concussion, Targeting Unmet Need in Mild Traumatic Brain Injury 1 - Minichart

Apr 13, 2026

Apr 13, 2026

Oragenics doses first patient in Phase IIa trial of ONP-002 for concussion - TradingView — Track All Markets

Apr 13, 2026

Apr 13, 2026

With no approved concussion drug, Oragenics starts patient dosing - Stock Titan

Apr 13, 2026

Apr 11, 2026

Sectors Review: Is Oragenics Inc stock technically oversold2026 Institutional & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

Oragenics (OGEN) Short Interest & Short Float | Updated Apr 2026 - MarketBeat

Apr 10, 2026

Apr 09, 2026

Nasdaq Moves: Is Oragenics Inc vulnerable to short sellersQuarterly Market Review & Risk Controlled Stock Pick Alerts - baoquankhu1.vn

Apr 09, 2026

Apr 09, 2026

Risk On: Is Oragenics Inc gaining market sharePrice Action & Advanced Technical Signal Analysis - baoquankhu1.vn

Apr 09, 2026

Apr 09, 2026

Rally Mode: Is Oragenics Inc gaining market share2026 Trading Volume Trends & Long-Term Capital Growth Strategies - baoquankhu1.vn

Apr 09, 2026

Apr 04, 2026

0A64.IL,0P0001LL1F,111 (0A64.IL) Latest Press Releases & Corporate News - Yahoo! Finance Canada

Apr 04, 2026

Apr 03, 2026

Oragenics Inc (UAV.BE) Stock Price, News, Quote & History - ca.finance.yahoo.com

Apr 03, 2026

Apr 02, 2026

OGEN Stock Price, Quote & Chart | ORAGENICS INC (NYSEARCA:OGEN) - ChartMill

Apr 02, 2026

Apr 01, 2026

Oragenics Sets New 2025 Annual Shareholder Meeting Date - The Globe and Mail

Apr 01, 2026

Mar 31, 2026

Oragenics: CEO Highlights "Undervalued" Pipeline Amid Significant Insider Sale of 35% Ownership - Bitget

Mar 31, 2026

Mar 31, 2026

Oragenics (OGEN) schedules 2025 shareholder meeting and sets May 1, 2026 proposal cutoff - Stock Titan

Mar 31, 2026

Mar 29, 2026

Risks Report: What is the target price for Oragenics Inc stockDollar Strength & Real-Time Stock Movement Alerts - baoquankhu1.vn

Mar 29, 2026

Mar 26, 2026

Oragenics Receives Going Concern Qualification Amid Clinical Trial Preparations - citybuzz -

Mar 26, 2026

Mar 26, 2026

Oragenics, Inc. Receives Audit Opinion with Going Concern Explanation - Sahm

Mar 26, 2026

Mar 25, 2026

Oragenics (OGEN) Reports Going Concern Risk in Latest Audit - GuruFocus

Mar 25, 2026

Mar 25, 2026

OGEN SEC FilingsOragenics 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 25, 2026

Mar 23, 2026

Volume Recap: Is Oragenics Inc vulnerable to short sellers2026 Support & Resistance & Long Hold Capital Preservation Tips - baoquankhu1.vn

Mar 23, 2026

Mar 23, 2026

[EFFECT] ORAGENICS INC SEC Filing - Stock Titan

Mar 23, 2026

Mar 23, 2026

If You Invested $1,000 in Oragenics (OGEN) - Stock Titan

Mar 23, 2026

Mar 22, 2026

Growth Report: Is Oragenics Inc forming bullish engulfing patterns2026 Decliners & AI Powered Buy/Sell Recommendations - baoquankhu1.vn

Mar 22, 2026

Mar 20, 2026

Oragenics, Inc.: Fundamental Analysis and Financial Ratings | UAV0 | US6840236094 - marketscreener.com

Mar 20, 2026

Mar 20, 2026

OGEN Forecast, Price Target & Analyst Ratings | ORAGENICS INC (NYSEARCA:OGEN) - ChartMill

Mar 20, 2026

Mar 19, 2026

Oragenics (NASDAQ: OGEN) updates S-3/A with auditor consent - Stock Titan

Mar 19, 2026

Mar 17, 2026

Oragenics Files 2025 Annual Report, Highlights Progress in Concussion Treatment Development - citybuzz -

Mar 17, 2026

Mar 17, 2026

Oragenics Submits Annual Report Highlighting Fiscal Year 2025 Financials and Research Updates - geneonline.com

Mar 17, 2026

Mar 17, 2026

ORAGENICS FILES ANNUAL REPORT ON FORM 10-K - The Manila Times

Mar 17, 2026

Mar 17, 2026

Biotech Oragenics raises $16.5M, clears debt to fund concussion drug trial - Stock Titan

Mar 17, 2026

Mar 16, 2026

Oragenics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 16, 2026

Mar 15, 2026

Oragenics, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com

Mar 15, 2026

Mar 13, 2026

ORAGENICS INITIATES PHASE IIA CLINICAL TRIAL SITE ACTIVATION - Sahm

Mar 13, 2026

Mar 13, 2026

Oragenics Initiates First Clinical Site for Phase IIa Trial of Intranasal Concussion Treatment - citybuzz -

Mar 13, 2026

Mar 12, 2026

Oragenics Inc Initiates Phase Iia Clinical Trial Site Activation - marketscreener.com

Mar 12, 2026

Mar 12, 2026

Oragenics (OGEN) Advances Phase IIa Clinical Trial of ONP-002 in Australia - GuruFocus

Mar 12, 2026

Mar 12, 2026

Oragenics begins testing nasal concussion treatment in Australia - Stock Titan

Mar 12, 2026

Mar 12, 2026

Oragenics Receives Australian HREC Approval to Begin Phase IIa Trial of ONP-002 for Concussion and Mild Traumatic Brain Injury - Minichart

Mar 12, 2026

Mar 11, 2026

Oragenics Advances Concussion Drug Trial and Explores CNS Asset Acquisitions - TipRanks

Mar 11, 2026

Mar 11, 2026

Oragenics Explores CNS Asset Acquisitions to Expand Brain Health Pipeline - citybuzz -

Mar 11, 2026

Mar 11, 2026

Oragenics (OGEN) Eyes Expansion in Central Nervous System Sector - GuruFocus

Mar 11, 2026

Mar 11, 2026

ORAGENICS EXPLORES EXPANSION OF CNS PLATFORM PURSUING ACQUISTION OF ASSETS IN BRAIN HEALTH, RECOVERY, AND NEUROPROTECTION - The Manila Times

Mar 11, 2026

Mar 11, 2026

Oragenics Explores Expansion of CNS Platform - Moomoo

Mar 11, 2026

Mar 10, 2026

Oragenics (OGEN) Receives Approval for Phase IIa Concussion Drug Trial in Australia - GuruFocus

Mar 10, 2026

Mar 10, 2026

Oragenics Receives HREC Approval for Phase IIa Clinical - GlobeNewswire

Mar 10, 2026

Mar 07, 2026

Is Oragenics Inc forming bullish engulfing patterns2025 Key Highlights & Daily Momentum Trading Reports - baoquankhu1.vn

Mar 07, 2026

Mar 07, 2026

Inflation Data: Is Oragenics Inc a strong candidate for buy and holdJuly 2025 Sentiment & High Return Trade Guides - baoquankhu1.vn

Mar 07, 2026

Mar 04, 2026

Aug Technicals: What is the target price for Oragenics Inc stockPortfolio Performance Report & Momentum Based Trading Signals - baoquankhu1.vn

Mar 04, 2026

Feb 28, 2026

OGEN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 28, 2026

Feb 18, 2026

Momentum Shift: Is Oragenics Inc vulnerable to short sellersJuly 2025 Update & Weekly Breakout Stock Alerts - baoquankhu1.vn

Feb 18, 2026

Feb 17, 2026

How Oragenics Inc. stock trades pre earningsJuly 2025 Pullbacks & Risk Managed Investment Entry Signals - mfd.ru

Feb 17, 2026

Feb 13, 2026

OGEN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 13, 2026

Feb 13, 2026

OGEN Should I Buy - Intellectia AI

Feb 13, 2026

Feb 12, 2026

Can Oragenics Inc. sustain its profitabilityJuly 2025 Macro Moves & Consistent Return Investment Signals - mfd.ru

Feb 12, 2026

Feb 11, 2026

Is Oragenics Inc. vulnerable to short sellers2025 Key Lessons & Verified Chart Pattern Signals - mfd.ru

Feb 11, 2026